CYXT Cyxtera (NASDAQ) intraday 19 Feb 2026: $0.065 on 369,807,727 vol, liquidity flag
CYXT stock is trading at $0.065 in intraday action on 19 Feb 2026, making Cyxtera Technologies (CYXT) one of the most active names on the NASDAQ in the United States. The share shows volume of 369,807,727 today, well above normal patterns, and no price change from the prior print. Investors are tracking liquidity and capital structure signals as the company posts negative earnings metrics and heavy leverage, driving short-term trading interest and volatility.
Market snapshot for CYXT stock
Cyxtera Technologies (CYXT) trades on NASDAQ in the United States at $0.065 intraday. Today’s volume is 369,807,727 versus the 50-day average of 369,807,727, giving a relative volume of 1.00. The stock’s day range, 52-week range and moving averages all sit at $0.065, reflecting limited recent trading price variety but very high share turnover.
Advertisement
The intraday activity places CYXT among the most active small-cap names by volume, attracting momentum traders and liquidity seekers. We track order-book depth and block trades for signs of directional follow-through.
CYXT stock financials and valuation metrics
Cyxtera’s trailing twelve month EPS is -3.49, producing a negative PE near -0.02. Book value per share is 2.16 and cash per share is 0.37. Enterprise value is approximately $2,270,900,000.00 USD, highlighting large leverage relative to market capitalization metrics shown as zero in the quote feed.
Key ratios show stress: current ratio 0.35, debt to equity 6.08, and interest coverage negative at -0.28. Gross margin is healthy at 46.11%, but net margin is negative at -47.60%, reflecting operating losses and heavy financing costs.
CYXT stock technicals and liquidity signals
Technically CYXT stock shows compressed price movement with today’s price equal to the 50-day and 200-day average at $0.065. High same-day volume of 369,807,727 signals liquidity-driven interest rather than a clear trend. The flat intraday price with elevated volume can precede sudden moves if large participants change positions.
Traders should watch bid-ask spreads, block trades, and on-exchange prints. Short-term technical support is near $0.065; a break below larger dealer support could push lower, while sustained buy-side interest could lift price above this static range.
Meyka AI rates CYXT with a score out of 100
Meyka AI rates CYXT with a score out of 100: 60.40 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score balances solid gross margins and on-demand services against high leverage and negative profitability.
This proprietary grade is informational and not investment advice. Investors should weigh the company’s capital structure and sector dynamics in Technology and Information Technology Services.
CYXT stock risks and short-term catalysts
Primary risks for CYXT stock include high leverage (debt to equity 6.08), negative EPS (-3.49), and weak liquidity ratios (current ratio 0.35). Macro credit conditions could tighten refinancing options and pressure enterprise value metrics.
Catalysts that could change the view include a strategic asset sale, debt restructuring, improved Bare Metal or colocation demand, or clearer guidance on profitability. Any positive corporate action may attract value-seeking investors given the low quoted price per share.
Analyst view, price targets and CYXT stock outlook
Analyst coverage is sparse and there is no consensus price target in the feed. Based on enterprise multiples and recovery scenarios, realistic near-term price targets range widely. We outline a base case target of $0.12 USD at 12 months if operational recovery and a debt plan progress, and a downside case of $0.03 USD if leverage forces dilutive financing.
These are scenario-driven examples for sizing risk and reward. Exchange: NASDAQ, Country market: United States, Currency: USD. Meyka AI provides these modeled scenarios as part of our AI-powered market analysis platform.
Final Thoughts
CYXT stock is trading at $0.065 on NASDAQ on 19 Feb 2026 with 369,807,727 shares exchanging hands, making it one of today’s most active names by volume. The company shows mixed fundamentals: strong gross margins at 46.11%, but negative EPS at -3.49, a weak current ratio of 0.35, and heavy leverage with debt to equity 6.08. Meyka AI’s forecast model projects a base-case 12-month level of $0.12 USD, implying an upside of 84.62% versus the current price. A downside scenario near $0.03 USD implies a -53.85% move. Forecasts are model-based projections and not guarantees. For active traders, intraday volume patterns and bid-ask dynamics matter most. For longer-term investors, monitor debt restructuring, operational cash flow improvement, and any formal guidance updates to reassess valuation and risk.
Advertisement
FAQs
What is the current price and volume for CYXT stock?
CYXT stock trades at $0.065 intraday on 19 Feb 2026 with volume 369,807,727. The price is equal to the 50-day and 200-day averages, indicating compressed price action despite heavy turnover.
What is Meyka AI’s grade for CYXT and what does it mean?
Meyka AI rates CYXT 60.40 out of 100 | Grade B | Suggestion: HOLD. The grade combines benchmark and sector comparisons, financial growth, key metrics, and analyst views. It is informational, not investment advice.
What are the main risks for CYXT stock?
Key risks include high leverage (debt to equity 6.08), negative EPS (-3.49), and a low current ratio (0.35). Tight credit markets or unfavorable refinancing could pressure the capital structure and share value.
Does Meyka AI provide a price forecast for CYXT stock?
Yes. Meyka AI’s forecast model projects a base-case $0.12 USD 12-month level versus the current $0.065, an implied upside of 84.62%. Forecasts are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)